OpenCitations
Works that cite this article, indexed by OpenCitations.
A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis
AGING MEDICINE 8(3) (2025)
Nitin Kapoor; Thomas Paul; Rajeshwar Nath Srivastava; Saurabh Singh; Sunil Maheshwari; Vishal Patil; Awadhesh Kumar Yadav; Girish Bhatia; Sushil H. Mankar; Joe Joseph Cherian; Surabhi Maheshwari; Sudeepti Srivastava; Dattatray Pawar; Roshan Pawar; Amol Aiwale; Amitrajit Pal; Yogesh Rane; Vinayaka Shahavi; Akhilesh Sharma
QALY league table of Iran: a practical method for better resource allocation
Cost Effectiveness and Resource Allocation 19(1) (2021)
Reza Hashempour; Behzad Raei; Majid Safaei Lari; Nasrin Abolhasanbeigi Gallezan; Ali AkbariSari
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa
Applied Health Economics and Health Policy 20(3) (2021)
Mouaddh Abdulmalik Nagi; Pramitha Esha Nirmala Dewi; Montarat Thavorncharoensap; Sermsiri Sangroongruangsri
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
PharmacoEconomics 39(2) (2020)
Nannan Li; Dennis Cornelissen; Stuart Silverman; Daniel Pinto; Lei Si; Ingrid Kremer; Sandrine Bours; Robin de Bot; Annelies Boonen; Silvia Evers; Joop van den Bergh; Jean-Yves Reginster; Mickaël Hiligsmann